Saviana Nedeianu
Overview
Explore the profile of Saviana Nedeianu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurban P, Mambet C, Botezatu A, Necula L, Matei L, Neagu A, et al.
Am J Hematol
. 2024 Oct;
100(1):168-171.
PMID: 39425629
No abstract available.
2.
Gurban P, Mambet C, Botezatu A, Necula L, Matei L, Neagu A, et al.
J Cell Mol Med
. 2024 Aug;
28(16):e70024.
PMID: 39183370
BCR::ABL1-negative myeloproliferative neoplasms (MPNs) are clonal haematopoietic stem cell disorders characterized by specific driver mutations and an increased risk of both macrothrombosis and microthrombosis. Serotonin receptor type 1B (HTR1B) was...
3.
Iancu I, Diaconu C, Plesa A, Fudulu A, Albulescu A, Neagu A, et al.
J Cell Mol Med
. 2024 Mar;
28(7):e18226.
PMID: 38501860
More than 3 years after the start of SARS-CoV-2 pandemic, the molecular mechanisms behind the viral pathogenesis are still not completely understood. Long non-coding RNAs (lncRNAs), well-known players in viral...
4.
Gurban P, Mambet C, Botezatu A, Necula L, Neagu A, Matei L, et al.
Front Oncol
. 2023 Oct;
13:1266996.
PMID: 37841434
Somatic frameshift mutations in exon 9 of calreticulin () gene are recognized as disease drivers in primary myelofibrosis (PMF), one of the three classical Philadelphia-negative myeloproliferative neoplasms (MPNs). Type 1/type...
5.
Chivu-Economescu M, Bleotu C, Grancea C, Chiriac D, Botezatu A, Iancu I, et al.
J Cell Mol Med
. 2022 Jan;
26(4):1293-1305.
PMID: 35043552
SARS-CoV-2 vaccines are highly efficient against severe forms of the disease, hospitalization and death. Nevertheless, insufficient protection against several circulating viral variants might suggest waning immunity and the need for...
6.
Necula L, Matei L, Dragu D, Neagu A, Mambet C, Nedeianu S, et al.
World J Gastroenterol
. 2019 May;
25(17):2029-2044.
PMID: 31114131
Gastric cancer (GC) remains an important cause of cancer death worldwide with a high mortality rate due to the fact that the majority of GC cases are diagnosed at an...
7.
Pignitter M, Gorren A, Nedeianu S, Schmidt K, Mayer B
Free Radic Biol Med
. 2006 Jul;
41(3):455-63.
PMID: 16843826
Uncoupling of nitric-oxide synthase (NOS) by deficiency of the substrate L-arginine or the cofactor (6R)-5,6,7,8-tetrahydrobiopterin (BH4) is known to generate the reactive oxygen species H2O2 and superoxide. Discrimination between these...
8.
Nedeianu S, Pali T, Marsh D
Biochim Biophys Acta
. 2004 Mar;
1661(2):135-43.
PMID: 15003876
S-nitroso-N-acetylpenicillamine (SNAP) is a pharmacological agent with diverse biological effects that are mainly attributable to its favorable characteristics as a nitric oxide (NO)-evolving agent. It is found that SNAP incorporates...
9.
Nedeianu S, Pali T
Cell Mol Biol Lett
. 2002 Apr;
7(1):142-3.
PMID: 11944070
Two commonly used hydrophobic and hydrophilic spin traps for NO, namely Fe2+(DETC)(2)and Fe2+(MGD)(2), respectively, were analyzed via EPR spectroscopy. EPR spectra of trapped NO, together with field position standards, were...